vs
SIERRA BANCORP（BSRR）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
SIERRA BANCORP的季度营收约是RECURSION PHARMACEUTICALS, INC.的1.1倍（$39.3M vs $35.5M），SIERRA BANCORP净利率更高（40.4% vs -304.2%，领先344.6%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs 3.8%），SIERRA BANCORP自由现金流更多（$32.2M vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs 2.6%）
Sierra Bancorp是总部位于美国加利福尼亚州的地区性银行控股公司，运营Bank of the Sierra品牌，提供存款、消费贷款、商业信贷、按揭等零售及商业银行业务，主要服务加州中南部的本地社区、中小企业及个人客户。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
BSRR vs RXRX — 直观对比
营收规模更大
BSRR
是对方的1.1倍
$35.5M
营收增速更快
RXRX
高出678.0%
3.8%
净利率更高
BSRR
高出344.6%
-304.2%
自由现金流更多
BSRR
多$79.5M
$-47.3M
两年增速更快
RXRX
近两年复合增速
2.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $39.3M | $35.5M |
| 净利润 | $12.9M | $-108.1M |
| 毛利率 | — | 59.8% |
| 营业利润率 | 43.6% | -304.8% |
| 净利率 | 40.4% | -304.2% |
| 营收同比 | 3.8% | 681.7% |
| 净利润同比 | 24.4% | 39.6% |
| 每股收益（稀释后） | $0.96 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BSRRRXRX
| Q4 25 | $39.3M | $35.5M | ||
| Q3 25 | $40.0M | $5.2M | ||
| Q2 25 | $39.2M | $19.2M | ||
| Q1 25 | $36.8M | $14.7M | ||
| Q4 24 | $37.9M | $4.5M | ||
| Q3 24 | $38.6M | $26.1M | ||
| Q2 24 | $37.8M | $14.4M | ||
| Q1 24 | $37.3M | $13.8M |
净利润BSRRRXRX
| Q4 25 | $12.9M | $-108.1M | ||
| Q3 25 | $9.7M | $-162.3M | ||
| Q2 25 | $10.6M | $-171.9M | ||
| Q1 25 | $9.1M | $-202.5M | ||
| Q4 24 | $10.4M | $-178.9M | ||
| Q3 24 | $10.6M | $-95.8M | ||
| Q2 24 | $10.3M | $-97.5M | ||
| Q1 24 | $9.3M | $-91.4M |
毛利率BSRRRXRX
| Q4 25 | — | 59.8% | ||
| Q3 25 | — | -183.8% | ||
| Q2 25 | — | -4.9% | ||
| Q1 25 | — | -48.0% | ||
| Q4 24 | — | -181.4% | ||
| Q3 24 | — | 53.7% | ||
| Q2 24 | — | 36.2% | ||
| Q1 24 | — | 19.1% |
营业利润率BSRRRXRX
| Q4 25 | 43.6% | -304.8% | ||
| Q3 25 | 31.7% | -3327.6% | ||
| Q2 25 | 36.3% | -916.8% | ||
| Q1 25 | 33.4% | -1297.9% | ||
| Q4 24 | 33.3% | -4042.4% | ||
| Q3 24 | 37.4% | -377.1% | ||
| Q2 24 | 37.6% | -697.4% | ||
| Q1 24 | 33.9% | -698.4% |
净利率BSRRRXRX
| Q4 25 | 40.4% | -304.2% | ||
| Q3 25 | 24.2% | -3135.3% | ||
| Q2 25 | 27.1% | -894.2% | ||
| Q1 25 | 24.8% | -1373.3% | ||
| Q4 24 | 34.1% | -3935.5% | ||
| Q3 24 | 27.5% | -367.5% | ||
| Q2 24 | 27.2% | -676.6% | ||
| Q1 24 | 25.0% | -662.4% |
每股收益（稀释后）BSRRRXRX
| Q4 25 | $0.96 | $-0.17 | ||
| Q3 25 | $0.72 | $-0.36 | ||
| Q2 25 | $0.78 | $-0.41 | ||
| Q1 25 | $0.65 | $-0.50 | ||
| Q4 24 | $0.73 | $-0.56 | ||
| Q3 24 | $0.74 | $-0.34 | ||
| Q2 24 | $0.71 | $-0.40 | ||
| Q1 24 | $0.64 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $135.6M | $743.3M |
| 总债务越低越好 | $49.5M | $9.6M |
| 股东权益账面价值 | $364.9M | $1.1B |
| 总资产 | $3.8B | $1.5B |
| 负债/权益比越低杠杆越低 | 0.14× | 0.01× |
8季度趋势，按日历期对齐
现金及短期投资BSRRRXRX
| Q4 25 | $135.6M | $743.3M | ||
| Q3 25 | $95.5M | $659.8M | ||
| Q2 25 | $130.0M | $525.1M | ||
| Q1 25 | $159.7M | $500.5M | ||
| Q4 24 | $100.7M | $594.4M | ||
| Q3 24 | $132.8M | $427.6M | ||
| Q2 24 | $184.0M | $474.3M | ||
| Q1 24 | $119.2M | $296.3M |
总债务BSRRRXRX
| Q4 25 | $49.5M | $9.6M | ||
| Q3 25 | $49.5M | $11.9M | ||
| Q2 25 | $49.4M | $14.2M | ||
| Q1 25 | $49.4M | $16.4M | ||
| Q4 24 | $49.4M | $19.0M | ||
| Q3 24 | $49.4M | $20.5M | ||
| Q2 24 | $49.3M | $22.9M | ||
| Q1 24 | $49.3M | — |
股东权益BSRRRXRX
| Q4 25 | $364.9M | $1.1B | ||
| Q3 25 | $360.1M | $1.0B | ||
| Q2 25 | $355.7M | $919.1M | ||
| Q1 25 | $351.8M | $933.9M | ||
| Q4 24 | $357.3M | $1.0B | ||
| Q3 24 | $358.7M | $524.6M | ||
| Q2 24 | $350.0M | $584.4M | ||
| Q1 24 | $345.1M | $401.2M |
总资产BSRRRXRX
| Q4 25 | $3.8B | $1.5B | ||
| Q3 25 | $3.7B | $1.4B | ||
| Q2 25 | $3.8B | $1.3B | ||
| Q1 25 | $3.6B | $1.3B | ||
| Q4 24 | $3.6B | $1.4B | ||
| Q3 24 | $3.7B | $726.5M | ||
| Q2 24 | $3.7B | $775.9M | ||
| Q1 24 | $3.6B | $557.8M |
负债/权益比BSRRRXRX
| Q4 25 | 0.14× | 0.01× | ||
| Q3 25 | 0.14× | 0.01× | ||
| Q2 25 | 0.14× | 0.02× | ||
| Q1 25 | 0.14× | 0.02× | ||
| Q4 24 | 0.14× | 0.02× | ||
| Q3 24 | 0.14× | 0.04× | ||
| Q2 24 | 0.14× | 0.04× | ||
| Q1 24 | 0.14× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $33.7M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $32.2M | $-47.3M |
| 自由现金流率自由现金流/营收 | 81.9% | -133.1% |
| 资本支出强度资本支出/营收 | 3.9% | 3.5% |
| 现金转化率经营现金流/净利润 | 2.61× | — |
| 过去12个月自由现金流最近4个季度 | $50.8M | $-378.3M |
8季度趋势，按日历期对齐
经营现金流BSRRRXRX
| Q4 25 | $33.7M | $-46.1M | ||
| Q3 25 | $14.9M | $-117.4M | ||
| Q2 25 | $-35.9M | $-76.4M | ||
| Q1 25 | $40.6M | $-132.0M | ||
| Q4 24 | $57.2M | $-115.4M | ||
| Q3 24 | $27.4M | $-59.2M | ||
| Q2 24 | $620.0K | $-82.2M | ||
| Q1 24 | $7.0M | $-102.3M |
自由现金流BSRRRXRX
| Q4 25 | $32.2M | $-47.3M | ||
| Q3 25 | $14.7M | $-117.6M | ||
| Q2 25 | $-36.3M | $-79.6M | ||
| Q1 25 | $40.2M | $-133.8M | ||
| Q4 24 | $56.0M | $-116.7M | ||
| Q3 24 | $27.3M | $-63.8M | ||
| Q2 24 | $202.0K | $-83.4M | ||
| Q1 24 | $6.6M | $-109.0M |
自由现金流率BSRRRXRX
| Q4 25 | 81.9% | -133.1% | ||
| Q3 25 | 36.7% | -2272.5% | ||
| Q2 25 | -92.6% | -413.9% | ||
| Q1 25 | 109.5% | -907.4% | ||
| Q4 24 | 147.9% | -2567.7% | ||
| Q3 24 | 70.7% | -244.6% | ||
| Q2 24 | 0.5% | -578.5% | ||
| Q1 24 | 17.7% | -789.9% |
资本支出强度BSRRRXRX
| Q4 25 | 3.9% | 3.5% | ||
| Q3 25 | 0.6% | 4.7% | ||
| Q2 25 | 1.2% | 16.4% | ||
| Q1 25 | 1.0% | 12.4% | ||
| Q4 24 | 3.1% | 28.6% | ||
| Q3 24 | 0.3% | 17.5% | ||
| Q2 24 | 1.1% | 8.2% | ||
| Q1 24 | 1.0% | 48.2% |
现金转化率BSRRRXRX
| Q4 25 | 2.61× | — | ||
| Q3 25 | 1.54× | — | ||
| Q2 25 | -3.37× | — | ||
| Q1 25 | 4.46× | — | ||
| Q4 24 | 5.51× | — | ||
| Q3 24 | 2.58× | — | ||
| Q2 24 | 0.06× | — | ||
| Q1 24 | 0.75× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
